| Literature DB >> 22997516 |
Abstract
Our paper is a study about metabolism syndrome (MS) incidence situations of different nationalities, including Uighur, Kazak and Han nationality in Xinjiang by means of a cross-sectional survey and compare differences and adaptabilities of applications of the diagnostic criteria for MS recommended by Adult Treatment Protocol III of National Cholesterol Education Program of America (ATP III), International Diabetes Federation (IDF) and Chinese Diabetes Society (CDS) in three groups of populations. Conclusion tell us, for Uighur population and Kazak population, IDF criterion and ATPIII criterion had a better consistence, and CDS criterion was worst. For Han population, CDS criterion and IDF criterion had a better consistence, and ATPIII criterion was worst. For the screening of MS incidence rate of Uighur and Kazak adult populations in Xinjiang region, ATPIII criterion was optimal, while CDS criterion was optimal for Han population. However, as for screening of clustering of multiple risk factors of MS, IDF criterion was better than other criteria for the three nationalities.Entities:
Year: 2012 PMID: 22997516 PMCID: PMC3444863 DOI: 10.1155/2012/212383
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
MS's risk factors detectable rate of Uighur, Kazak, and Han population diagnosed by three criterions (%).
| MS five components | Uighur population | Kazak population | Han population | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ATP III (%) | IDF (%) | CDS (%) | ATP III (%) | IDF (%) | CDS (%) | ATP III (%) | IDF (%) | CDS (%) | |
| Central obesity (abdominal girth ≥90/80 cm) | 91.43 | 100 | 91.58 | 98.83 | 100.00 | 92.57 | 81.20 | 100 | 72.77 |
| High TG (TG ≥1.7 mmol/L) | 86.67 | 81.58 | 85.63 | 29.32 | 28.30 | 33.66 | 67.41 | 61.85 | 76.06 |
| Low HDL-C (<1.04/1.3 mmol/L) | 72.79 | 62.67 | 50.51 | 50.68 | 56.79 | 32.67 | 52.79 | 50.25 | 41.78 |
| BP abnormal (≥130/85 mmHg) | 40.95 | 50.06 | 59.75 | 93.79 | 90.94 | 91.34 | 66.30 | 62.86 | 36.15 |
| BG abnormal (FPG/PPG ≥5.6/7.8 mmol/L) | 62.72 | 55.01 | 72.69 | 46.80 | 45.66 | 69.80 | 78.13 | 74.79 | 88.73 |
| ≥3 risk factors together | 98.64 | 97.9 | 92.81 | 100.00 | 96.23 | 91.34 | 100.00 | 98.49 | 89.91 |
MS's morbidity of Uighur, Kazak, and Han population diagnosed by three criterions among different age groups (%).
| Age (years) | Uighur population | Kazak population | Han population | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ATP III (%) | IDF (%) | CDS (%) | ATP III | IDF (%) | CDS (%) | ATP III | IDF (%) | CDS (%) | |
| 30~ | 27.58 | 28.71 | 13.86 | 14.06 | 14.85 | 9.79 | 28.40 | 23.83 | 14.69 |
| 40~ | 38.65 | 43.43 | 22.91 | 18.44 | 19.60 | 11.96 | 25.29 | 23.12 | 16.60 |
| 50~ | 43.83 | 48.29 | 34.38 | 39.85 | 40.23 | 32.18 | 28.78 | 21.43 | 15.31 |
| 60~ | 43.02 | 47.09 | 33.72 | 25.58 | 25.58 | 26.25 | 26.36 | 20.92 | 16.74 |
| 70~ | 25.82 | 35.00 | 22.50 | 18.84 | 18.84 | 17.39 | 24.21 | 16.84 | 23.16 |
|
| |||||||||
| Total | 35.80 | 39.41 | 23.72 | 23.21 | 23.88 | 18.21 | 27.03 | 22.40 | 16.04 |
|
| |||||||||
| Standardized rate | 29.64 | 35.88 | 19.17 | 21.29 | 21.96 | 16.65 | 27.18 | 20.39 | 16.02 |
Comparison of diagnosis consistency of three criterions among Uighur, Kazak, and Han population.
| Diagnostic criteria | Uighur population | Kazak population | Han population | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Coincidence rate | Youden index | Kappa value | Coincidence rate | Youden index | Kappa value | Coincidence rate | Youden index | Kappa value | |
| ATP III & IDF | 0.9026 | 0.7801 | 0.7928 | 0.9878 | 0.9568 | 0.9662 | 0.6269 | 0.0003 | 0.0003 |
| ATP III & CDS | 0.756 | 0.5354 | 0.4572 | 0.8526 | 0.6120 | 0.5530 | 0.6687 | 0.0471 | 0.0369 |
| IDF III & CDS | 0.7837 | 0.6301 | 0.5132 | 0.8513 | 0.6219 | 0.5547 | 0.7172 | 0.1106 | 0.0953 |
Comparison of three diagnostic criterions for metabolic syndrome.
| Item | ATP III* | IDFΔ | CDS# |
|---|---|---|---|
| Obesity or central obesity | WC ≥90 cm (male) or ≥80 cm (female) | WC ≥90 cm (male) or ≥80 cm (female) | BMI ≥0.25 (kg/m2) |
| High TG | TG ≥1.70 mmol/L | TG ≥1.70 mmol/L or diagnosed as high TG-hematic disease and received therapy | TG ≥1.7 mmol/L |
| Low HDL-C | HDL-C <1.04 mmol/L (male) or <1.30 mmol/L (female) | HDL-C <1.04 mmol/L (male) or <1.30 mmol/L (female), or diagnosed as low-HDL-C hematic disease and received therapy | And (or) HDL-C <0.9 mmol/L (male) or <1.0 mmol/L (female) |
| Hypertension | SBP/DBP ≥130/85 mmHg | SBP/DBP ≥130/85 mmHg, or diagnosed as hypertension and received therapy | SBP/DBP ≥140/90 mmHg, and (or) diagnosed as hypertension and received therapy |
| Glucose/Lipid metabolic abnormal | FPG ≥5.6 mmol/L or diagnosed as type 2 diabetes | FPG ≥6.1 mmol/L and /PPG ≥7.8 mmol/L, and (or) diagnosed as type 2 diabetes |
*Comply with at least any three of the five items; ΔAny two items plus obesity or central obesity; #possess three of the four items or all (High TG and low HDL-C was considered as one item).
Clinical and biochemistry data of Uighur, Kazak, and Han population ().
| Item | Uighur population | Kazak population | Han population | |||
|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | |
| Age (year) | 49.44 ± 13.07 | 46.43 ± 11.39 | 51.85 ± 12.23 | 43.24 ± 8.17 | 48.42 ± 12.14 | 44.91 ± 10.58 |
| BMI (Kg/M2) | 25.63 ± 4.29 | 26.34 ± 4.8 | 29.07 ± 4.42 | 27.87 ± 5.02 | 23.96 ± 4.39 | 26.07 ± 4.92 |
| FPG (mmol/L) | 5.58 ± 2.59 | 5.32 ± 1.9 | 4.99 ± 1.04 | 4.85 ± 1.00 | 5.76 ± 1.40 | 5.46 ± 0.99 |
| PPG (mmol/L) | 7.1 ± 3.8 | 6.87 ± 3.21 | 7.64 ± 1.92 | 7.60 ± 1.95 | 7.19 ± 3.34 | 5.84 ± 2.03 |
| SBP (mmHg) | 116.9 ± 17.9 | 114.6 ± 19.4 | 133.44 ± 25.81 | 130.18 ± 25.36 | 121.40 ± 20.11 | 112.86 ± 15.50 |
| DBP(mmHg) | 74.5 ± 11.8 | 74.1 ± 12.5 | 86.04 ± 15.34 | 83.17 ± 15.33 | 76.76 ± 11.58 | 73.89 ± 10.18 |
| TC (mmol/L) | 3.29 ± 1.49 | 3.38 ± 1.49 | 4.92 ± 0.88 | 4.72 ± 0.90 | 5.26 ± 1.01 | 5.03 ± 1.04 |
| TG (mmol/L) | 2.89 ± 1.95 | 2.61 ± 1.73 | 1.13 ± 0.98 | 1.91 ± 0.69 | 1.53 ± 0.95 | 1.41 ± 1.05 |
| HDL-C (mmol/L) | 1.22 ± 0.32 | 1.23 ± 0.31 | 1.55 ± 0.52 | 1.49 ± 0.45 | 1.50 ± 0.55 | 1.44 ± 0.55 |
| LDL-C (mmol/L) | 1.49 ± 1.60 | 1.63 ± 1.64 | 2.08 ± 1.15 | 1.89 ± 0.98 | 2.84 ± 1.03 | 2.60 ± 1.08 |
| WC (cm) | 89.86 ± 12.12 | 89.23 ± 12.51 | 95.18 ± 11.61 | 90.26 ± 12.41 | 84.61 ± 10.11 | 80.32 ± 10.51 |